The author is CEO, AIRA Matrix
Artificial Intelligence can optimise diagnostic workflows by augmenting non-invasive investigative modalities. Histopathological examination of biopsy tissue with ancillary procedures, is considered the gold standard for cancer diagnosis.
Deep Learning techniques are well suited to make a difference in complex, expensive processes like drug development.
Your e-mail iformation will not be shared with anyone else. And it will be used only to send out our latest news.